Complete Durable Response From Carboplatin and Olaparib in a Heavily Pretreated Triple-Negative Metastatic Breast Cancer With Germline BRCA2 and “BRCAness” Mutations
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.